Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bellicum Pharmaceuticals Appoints New CMO | Contract Pharma
Breaking News, Promotions & Moves

Bellicum Pharmaceuticals Appoints New CMO

William Grossman has a history in development of cancer immunotherapies and combinations

Bellicum Pharmaceuticals has appointed William Grossman, M.D., Ph.D., as chief medical officer, effective February 5. Dr. Grossman joins Bellicum from Genentech/Roche.

 

“We are excited to have Bill join Bellicum. His expertise in the development of cancer immunotherapies and combinations will strengthen our team as we advance and expand our CAR T and TCR pipeline and prepare for the regulatory filing and potential commercialization of BPX-501 in Europe,” said Bellicum’s president & chief executive officer, Rick Fair.

 

In his most recent role at Genentech, Dr. Grossman served as the Group Medical Director, Cancer Immunotherapy, where he led the global clinical development of TECENTRIQ in gastrointestinal cancers and of cancer immunotherapy combinations across all solid tumor types. Previously, he served as Senior Vice President, Research & Clinical Development at Biothera, where he oversaw all discovery and clinical development efforts in oncology and immunology. Dr. Grossman has also held leadership positions in research, clinical development, and medical affairs at AbbVie, Baxter Healthcare, and Merck & Co., where he was involved in the development and clinical study of cancer vaccines, immunomodulatory agents, and small molecules/biologics in oncology.

 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters